Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections (Q40675256)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1996

Language	Label	Description	Also known as
English	Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections	scientific article published on January 1996

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections (English)

1 reference

Europe PubMed Central

22 September 2017

imipenem/cilastatin

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

3

object named as

R N Brogden

1 reference

Europe PubMed Central

22 September 2017

author name string

J A Balfour

1

1 reference

Europe PubMed Central

22 September 2017

H M Bryson

2

1 reference

Europe PubMed Central

22 September 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

51

1 reference

Europe PubMed Central

22 September 2017

99-136

1 reference

Europe PubMed Central

22 September 2017

1

1 reference

Europe PubMed Central

22 September 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199651010-00008

0 references

Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A nationwide survey of antimicrobial susceptibilities of clinical isolates to antibiotics in Japan (1988-1990)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of Antimicrobial Drugs Evaluated by Agar Dilution and Radiometric Methods against Strains ofNocardia asteroidesIsolated in Italy from Immunocompromised Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pefloxacin versus imipenem in the therapy of nosocomial lung infections of intensive care unit patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of systemically administered antibiotics in patients with thermal injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of antibiotics against resistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility of Acinetobacter species

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of Bay Y3118 against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion of imipenem in synovial fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human vitreous penetration of imipenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro antimicrobial susceptibility of Rhodococcus equi

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of resistant Enterococcus faecium to unusual antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of stably derepressed class-I -lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of beta-lactamase inducibility and derepression on the activity of cefpirome against gram-negative bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of biapenem, a new carbapenem antibiotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pneumonia treated with imipenem/cilastatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to third-generation cephalosporins in Barbados

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of L-627 against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cross-reactivity and immunology of beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human pancreatic tissue concentration of bactericidal antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of anaerobic bacteria to antimicrobial agents in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of Pseudomonas aeruginosa to anti-pseudomonal antibiotics in a general hospital in Spain from 1989 to 1992

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose pharmacokinetics of imipenem in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility of anaerobic bacteria in Australia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin therapy for serious infections in neonates and infants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/Cilastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal clearance of imipenem in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibilities of enterococci isolated from hospitalized patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Pseudomonas aeruginosa to imipenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of monobactams and carbapenems.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enterococcal superinfection in paediatric oncology patients treated with imipenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outbreak of a nosocomial infection of SHV2-beta-lactamase-containing Klebsiella pneumonia strains in an operative intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of imipenem/cilastatin in endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic antibiotic treatment of nosocomial pneumonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity and beta-lactamase stability of LJC 10,627

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to imipenem among selected gram-negative bacilli in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin in the treatment of osteomyelitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a combination treatment using imipenem/cilastatin sodium with G-CSF on infections in neutropenic patients with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical phase I study on intramuscular imipenem/cilastatin sodium

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective surveillance of imipenem/cilastatin use and associated seizures using a hospital information system

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of imipenem/cilastatin in the treatment of soft tissue infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study on the convulsant activity of carbapenems and beta-lactams

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing antimicrobial activity against resistant Pseudomonas aeruginosa using an index for the absence of cross-resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre study: Staphylococcus and Enterococcus susceptibility to antibiotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem prophylaxis in elective colorectal surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose imipenem-cilastatin compared with three doses of cefuroxime and metronidazole as prophylaxis in elective colorectal surgery: a prospective randomized study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of imipenem and amikacin combinations against resistant Pseudomonas aeruginosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin: a pharmacoeconomic appraisal of its use in intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-627, a novel carbapenem: in-vitro activity against anaerobes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem in biological fluids analysed by derivative UV-spectrophotometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[In vitro study of the sensitivity to antibiotics of 213 Pseudomonas aeruginosa strains isolated in an intensive care unit of the Sfax Hospital (Tunisia)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem in patients undergoing major colon surgery.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial resistance in Bacteroides

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of resistance to the carbapenems.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics during continuous haemofiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First- and second-derivative spectrophotometric determination of imipenem and cilastatin in injections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of imipenem in neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefotaxime-resistant Gram-negative bacilli in a University Hospital: occurrence, identity, source and sensitivity patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of multidrug-resistant isolates of Acinetobacter baumannii.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Sensitivity of penicillin-resistance pneumococci]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diversity of klebsiellae with extended-spectrum beta-lactamases at a Turkish university hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and transplacental passage of imipenem during pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem/cilastatin sodium in children with peritonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate hypersensitivity reactions to beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious complications in the immunocompromised host. The antimicrobial armamentarium

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe neutropenia in a patient treated with imipenem/cilastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin as monotherapy in severe infections: comparison with cefotaxime in combination with metronidazole and cloxacillin. Report from a Norwegian Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acinetobacter in Denmark: I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem in the treatment of patients with severe surgical infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of methicillin-resistant Staphylococcus aureus associated with nosocomial infections in the University Hospital, Kuala Lumpur

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The postantibiotic effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotics, biliary sepsis, and bile duct stones.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of imipenem and cilastatin sodium in Primaxin by first order derivative ultraviolet spectrophotometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey of Bacteroides fragilis group susceptibility patterns in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of L-627, a new carbapenem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical effects of imipenem/cilastatin sodium on gynecological infections]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of imipenem and cilastatin in premature infants during the first week of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of anaerobic bacteria to PD 131628

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sodium imipenem/cilastatin on patients of complicated urinary tract infections--following the failure of prior antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin treatment of bacterial meningitis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antimicrobial susceptibilities of Nocardia species

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis and treatment of endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8741235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199651010-00008

1 reference

Europe PubMed Central

22 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40675256&oldid=2144461094"